Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP607-QIV vs Agrippal in Children Aged 6-35 Months
NCT03704740Phase 3Completed
- Sponsor
- SK bioscience
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of NBP607-V in influenza, sponsored by SK bioscience. Started Oct 2018; status: completed.
02
Drugs
NBP607-V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03704740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03704740.